Essential IECIC Compliance Resources for Cosmetics in China

1. Introduction: What Is the IECIC and Why It Matters

The Inventory of Existing Cosmetic Ingredients in China (IECIC) — officially 已使用化妆品原料目录 in Chinese — is the definitive regulatory list of ingredients that are recognized as lawfully permitted for use in cosmetic products manufactured or sold in China. Any ingredient not listed on the IECIC is, by default, classified as a “new cosmetic ingredient” (化妆品新原料) and requires a separate, more rigorous notification or registration process before it can be used in cosmetic products sold in China.

For foreign beauty brands, understanding and complying with the IECIC is not optional — it is the foundational gatekeeping step in the entire NMPA filing process. Before you can prepare testing reports, compile a Safety Assessment Report, or even begin assembling your NMPA notification dossier, you must first verify that every single ingredient in your product formulation is IECIC-compliant.

This guide provides comprehensive resources for foreign beauty brands to navigate IECIC compliance — from understanding the inventory’s structure and limitations to using search tools, cross-referencing international inventories, and managing the new ingredient pathway when needed.

2. History and Evolution of the IECIC

2.1 Pre-2015: Fragmented Ingredient Lists

Before the IECIC’s creation, China’s cosmetics ingredient regulation relied on a patchwork of lists, including the “Hygienic Standards for Cosmetics” (化妆品卫生规范) and various provincial-level references. The lack of a unified inventory created significant uncertainty and inconsistency in the regulatory review process.

2.2 The First IECIC (2015)

The NMPA (then CFDA) published the first official IECIC in December 2015, containing approximately 8,783 entries. This was a watershed moment for the industry, providing — for the first time — a comprehensive, searchable reference for permitted cosmetic ingredients.

2.3 IECIC 2.0 (2021) — Post-CSAR Update

The most significant revision came with the implementation of CSAR (Cosmetic Supervision and Administration Regulation) in 2021. The updated IECIC, published under NMPA Announcement No. 2021-50, expanded the inventory to approximately 8,900+ entries and introduced several important structural changes:

• Standardized naming: Ingredients were aligned with international naming conventions where possible
• CAS number requirements: More rigorous CAS (Chemical Abstracts Service) number verification
• Categorized entries: Some ingredients were flagged with specific usage restrictions or concentration limits
• Expanded botanical coverage: Many traditional Chinese medicine (TCM) ingredients used in cosmetics were added

2.4 Ongoing Revisions

The NMPA continues to update the IECIC periodically. The most recent significant updates have covered:

• 2022 Update: Added approximately 80 new ingredients, primarily covering new preservatives and emollients
• 2023 Update: Expanded botanical ingredient coverage, especially for Asian plant species
• 2024–2025 Updates: Multiple targeted additions responding to industry petitions and international ingredient developments
• 2026 Current Status: The inventory now covers approximately 9,200+ ingredient entries

3. Current IECIC Structure and Content

3.1 Entry Format

Each IECIC entry contains the following information:

3.2 Key Categories Within the IECIC

• Common cosmetic ingredients: Emollients, surfactants, humectants, preservatives, fragrances, colorants, and film-formers
• Botanical extracts: Plant-derived ingredients used in cosmetic formulations
• Active ingredients: Functional ingredients with specific cosmetic claims (excluding NMPA-approved drug ingredients)
• Functional polymer ingredients: Film-formers, rheology modifiers, and thickeners
• Nanomaterial-designated ingredients: Ingredients with nano-scale variants, separately regulated under CSAR

3.3 What Is NOT Covered by IECIC

• Fragrance allergens: Not separately tracked in IECIC — managed through CSTS limits
• Processing aids: Substances used in manufacturing that do not remain in the final product
• Packaging materials: Not subject to ingredient-level compliance
• Prohibited ingredients: Managed through a separate prohibited ingredients list

4. Steps to Ensure IECIC Compliance

Step 1: Compile Your Complete Formulation

Create a detailed formulation spreadsheet with the following columns for each ingredient: Trade name, INCI name, CAS number, concentration (%), function, supplier. Every ingredient down to 0.001% must be listed — the NMPA does not accept “and other ingredients” or “fragrance” as a blanket entry.

Step 2: Standardize Ingredient Names

Map each ingredient to its IECIC-recognized name. If your formulation uses EU INCI or US INCI names, you must convert them to IECIC standard names. This is not always a 1:1 mapping — different English spelling conventions, different botanical name standards, and different hydration states can create discrepancies.

Step 3: Check Each Ingredient Against the IECIC

For each ingredient, verify:
– Is the ingredient listed on the current IECIC?
– Does the CAS number match?
– Are there any usage restrictions or concentration limits?
– Is the ingredient listed under the correct form/hydration state?
– Are there any special annotations (e.g., nano-material designation)?

Step 4: Document Gaps

For any ingredient not found on the IECIC, document:
– The nature of the ingredient (chemical, botanical, biotech-derived)
– Whether it may be listed under an alternate name
– Whether it qualifies as a “new cosmetic ingredient” under CSAR
– Whether there are known industry precedents for its approval in China

Step 5: Develop a Compliance Strategy

For ingredients not on the IECIC, choose one of these pathways:
– Reformulate: Replace with an IECIC-listed alternative (fastest, lowest risk)
– Submit a new ingredient notification: For lower-risk new ingredients
– Submit a new ingredient registration: For higher-risk new ingredients
– Seek a regulatory exception: In limited cases where international precedent supports safety

5. New Cosmetic Ingredients: The Path Beyond IECIC

5.1 Classification as a New Ingredient

Under CSAR, any ingredient not listed on the IECIC is classified as a “new cosmetic ingredient” (化妆品新原料). The process for registering a new ingredient depends on its risk classification:

5.2 Required Data for New Ingredient Submission

• Full chemical identification (name, CAS number, molecular structure, purity, impurities)
• Manufacturing process description and quality control specifications
• Toxicological data package (acute toxicity, skin irritation, eye irritation, skin sensitization, repeated-dose toxicity, reproductive toxicity, mutagenicity/genotoxicity, carcinogenicity as applicable)
• Safety assessment report
• Proposed usage concentration and product types
• International regulatory status (FDA, EU, Japan, Korea approvals if available)
• Stability data
• Impurity profile

6. IECIC Search and Cross-Reference Resources

6.1 Official NMPA Resources

• NMPA Cosmetics Data Search Platform: https://www.nmpa.gov.cn/datasearch/home-index.html — Free, officially maintained database. Allows searching by ingredient name (Chinese or English), CAS number, or product registration/notification number. Full Chinese-only interface.
• NMPA IECIC PDF Download: The complete IECIC is periodically published as a PDF on the NMPA website. The most recent version (as of July 2026) is the 2021 base with subsequent addenda.

6.2 Commercial and Third-Party Databases

• ChemLinked IECIC Database: English-language search interface with cross-referencing to EU CosIng, US INCI, and Japan’s JCIA ingredient lists. Subscription-based (approx. $1,000–$3,000/year for full access).
• CosIng-IECIC Cross-Reference Tool (SGS): Mapping tool that identifies whether EU CosIng-recognized ingredients are also on the IECIC. Free basic search, paid for full formulation reports.
• SkinCarisma China: Consumer-facing ingredient analysis tool that incorporates IECIC data. Useful for quick checks but not authoritative for regulatory filings.
• INCIDecoder China: Chinese-language ingredient decoding platform, helpful for understanding how ingredients are perceived by Chinese consumers but not sufficient for regulatory compliance verification.

6.3 Professional Advisory Services

• REACH24H Ingredient Compliance Desk: Full formulation IECIC gap analysis with detailed compliance recommendations
• Freyr Solutions Ingredient Review: Comprehensive IECIC compliance audit as part of broader NMPA filing support
• Intertek Regulatory Services: IECIC cross-referencing and new ingredient strategy development
• SGS China Cosmetics: Full formulation ingredient compliance check with Gap Analysis Report

7. Compliance Consulting and Ingredient Review Services

Given the complexity and high stakes of IECIC compliance — an incorrect ingredient judgment can derail an entire filing — most foreign beauty brands use professional consulting services for at least the initial ingredient audit. Here are the leading providers:

8. Common IECIC Compliance Pitfalls

8.1 CAS Number Mismatches

One of the most common reasons for IECIC non-compliance is CAS number discrepancies. An ingredient may appear to be on the IECIC by name, but if its CAS number differs (e.g., a different hydration state, isomer, or salt form), it may not be recognized as the same ingredient. Always verify by CAS number, not just by name.

8.2 Botanical Naming Variations

Botanical extracts are particularly problematic. The IECIC may list an ingredient under a specific botanical species name (e.g., Camellia sinensis leaf extract) while your formulation uses a different species or a different plant part (Camellia japonica seed oil). Even closely related species are not interchangeable for IECIC compliance.

8.3 Ingredient Complexes and Mixtures

Pre-formulated ingredient complexes (e.g., “HydraComplex 2000”) are not directly searchable on the IECIC. You must break down proprietary complexes into their individual components and check each one separately. If the supplier does not disclose full composition, the ingredient cannot be used in China.

8.4 Concentration Limits

Even if an ingredient is on the IECIC, it may have a maximum concentration limit. Using an ingredient above its IECIC-stated limit — even if it is technically safe — violates NMPA regulations.

8.5 Outdated IECIC Versions

Using an older version of the IECIC can lead to false negatives (thinking an ingredient is missing when it has since been added) or false positives (thinking an ingredient is listed when it has been removed or reclassified). Always use the current IECIC version and cross-reference with the latest NMPA announcements.

8.6 “Fragrance” and “Parfum” as Blanket Terms

Unlike in the EU and US, China requires detailed disclosure of fragrance components. “Fragrance” or “Parfum” is not an acceptable ingredient entry for NMPA filing. All individual fragrance compounds must be listed separately with their CAS numbers.

9. Monitoring IECIC Updates and Regulatory Changes

9.1 Subscribe to NMPA Announcements

The NMPA publishes regulatory announcements (公告) and notices (通知) on its website. Key categories to monitor:

• Cosmetics section: http://www.nmpa.gov.cn/WS04/CL2050/
• New ingredient approvals: Published as individual announcements when new ingredients are added to the IECIC
• Updated IECIC lists: Published when the inventory receives a bulk update (typically every 1–2 years)

9.2 Regulatory Intelligence Services

• ChemLinked Regulatory Tracker: English-language alerts for IECIC updates, new ingredient approvals, and regulatory changes. Customizable by ingredient category.
• Freyr Regulatory Radar: Global regulatory monitoring with China-specific feeds for cosmetics ingredients
• CosmeticsDesign Asia: Industry news covering China regulatory changes
• SGS SafeGuard: Regulatory alerts covering cosmetic ingredient changes in China and other markets

9.3 Industry Association Updates

• CAFFCI (China Association of Fragrance, Flavor and Cosmetic Industries): Regular member updates on IECIC developments. Foreign companies can join as international members.
• Personal Care Products Council (PCPC) China Desk: Industry advocacy and regulatory intelligence for US-based cosmetics companies
• Cosmetics Europe China Task Force: European cosmetic industry representation on Chinese ingredient regulation

10. IECIC vs. International Ingredient Inventories

Key Takeaway for Formulators: The IECIC contains approximately one-third the entries of CosIng or the US INCI list. Many ingredients approved in the EU or US are not yet on the IECIC. If you are developing a global formulation intended for the China market, check IECIC availability early in the R&D process — reformulation to substitute missing ingredients is far less costly than discovering the issue during NMPA filing.

11. Frequently Asked Questions

Q1: Can I use an ingredient that is not on the IECIC if it is approved in the EU or US?

No. Approval in the EU, US, Japan, or any other market does not automatically recognize the ingredient for use in China. Each ingredient must be individually listed on the IECIC or approved as a new cosmetic ingredient through the NMPA process.

Q2: How long does it take to add a new ingredient to the IECIC?

There is no standard timeline. The NMPA updates the IECIC periodically, and individual industry petitions can take 1–3 years for processing. For time-sensitive product launches, reformulation with IECIC-listed alternatives is generally the preferred approach.

Q3: How often is the IECIC updated?

Major revisions occur approximately every 1–2 years. Minor additions (individual new ingredient approvals) are published as NMPA announcements as they occur, and may be incorporated into the full IECIC list at the next major revision.

Q4: Do I need to check the IECIC for packaging materials?

No. Packaging materials are not cosmetic ingredients and are not subject to IECIC compliance. However, packaging must comply with applicable food-contact or cosmetic-contact material regulations.

Q5: What is the difference between IECIC and the “Prohibited Ingredients List”?

The IECIC tells you which ingredients are recognized as existing cosmetic ingredients in China. The “Catalogue of Prohibited and Restricted Cosmetic Ingredients” tells you which ingredients are banned or restricted in cosmetic products. An ingredient can be on the IECIC but prohibited from use in certain product types or above certain concentrations.

Q6: Can I reformulate after obtaining NMPA filing?

Yes, but any formulation change must be reported to the NMPA through the variation (变更) process. Substituting an ingredient requires re-verification of IECIC compliance for the new ingredient and may trigger re-testing requirements for the reformulated product.

Q7: How do I verify that a supplier’s ingredient is IECIC-compliant?

Request the supplier to provide the IECIC listing reference (serial number), Chinese standard name, and CAS number for each ingredient. For ingredient blends and complexes, request full formulation disclosure. A reputable supplier will provide this information as part of their China market documentation.

Q8: Are excipient/processing aids subject to IECIC?

Processing aids that do not remain in the final product at functional levels are generally not subject to IECIC compliance. However, any substance that remains in the finished product — even at low or trace levels — must be IECIC-compliant unless it qualifies as a processing aid under NMPA guidance.

Q9: What are the penalties for IECIC non-compliance?

Consequences range from rejection of the NMPA filing application (most common), to product seizure at customs, to fines, to recall of products already on the market, to suspension of the responsible person’s filing privileges. In severe cases involving safety issues, criminal penalties may apply.

Q10: Can fragrance companies submit proprietary blends to the IECIC?

No. The IECIC lists individual chemical substances. Fragrance blends (复合香精) are not listed as single entries. Each individual constituent of a fragrance compound must be on the IECIC, and their CAS numbers must be disclosed individually in the NMPA filing dossier. Confidential Business Information (CBI) protection is available for certain proprietary proportions.